Investors

Immunotherapy activated for real-world results

Inovio is putting IMMUNO-INGENUITY to work for the good of patients, healthcare providers, and global health.

Investor News:

See all news
NASD: INOVIO 4:00 PM 12/13/17
4.46 +0.21 +4.94% Volume: 1,443,359 Pricing delayed 20 minutes

See Inovio’s IMMUNO-INGENUITY, activated

E-mail alerts

Click here to register to receive e-mail alerts for Inovio news and events.

Sign up now

IR resources

Review information and download materials specialized for the investor audience.

See more

Financial reports and filings

Download quarterly reports, annual reports, and SEC filings.

See more

Upcoming and recent events

See all events

Corporate governance

Download our code of business conduct and ethics.

See more